Thank you @Sachin_and_Adam for stopping by and letting me share a glimpse into our product!
The video is a great intro to what we're working on at Chai - no bio background needed.
Exclusive: Inside $3.8B @chaidiscovery
After leaving OpenAI & Stripe, co-founders Josh Meier (@joshim5) and Jack Dent (@jackdent) built a pioneering AI drug design model called Chai-1. Now? Their models are used by giants like Eli Lilly, Pfizer and Novartis.
Their models
Today we are announcing our collaboration with Pfizer to put Chai's frontier AI—including our latest model, Chai-3—directly into the hands of one of the world's leading pharmaceutical teams.
Seeing one of the world's largest pharma companies move so quickly has been eye-opening for me.
Thrilled to have Lilly scientists using Chai's models. Their excitement is both contagious and a huge motivator.
We’re thrilled to announce our collaboration with @EliLillyandCo.
We’ll be deploying Chai’s AI models to power biologics discovery across a broad set of drug programs at Lilly.
This is a major step forward in pharma’s adoption of AI-native R&D.
I can't wait for the day these breakthroughs transform the lives of real people. In hindsight, $130M will have been a small price to pay.
We're hiring!
